Boundless Bio Shares Outstanding History (BOLD)
Boundless Bio reported 22.4M shares outstanding at the end of fiscal 2025.
View full Boundless Bio company overviewBoundless Bio annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 22.4M | 107,000 | +0.48% |
| 2024 | 2024-12-31 | 22.3M | 21.1M | +1688.27% |
| 2023 | 2023-12-31 | 1.2M | −21.0M | −94.39% |
| 2022 | 2022-12-31 | 22.2M | — | — |
Boundless Bio quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 22.5M | 89,000 | +0.40% |
| Q1 2026 | 2026-03-31 | 22.4M | 107,000 | +0.48% |
| Q4 2025 | 2025-12-31 | 22.4M | 107,000 | +0.48% |
| Q3 2025 | 2025-09-30 | 22.4M | 131,535 | +0.59% |
| Q2 2025 | 2025-06-30 | 22.4M | 131,898 | +0.59% |
| Q1 2025 | 2025-03-31 | 22.3M | 21.0M | +1666.14% |
| Q4 2024 | 2024-12-31 | 22.3M | 21.1M | +1688.27% |
| Q3 2024 | 2024-09-30 | 22.3M | — | — |
| Q2 2024 | 2024-06-30 | 22.3M | — | — |
| Q1 2024 | 2024-03-31 | 1.3M | — | — |
| Q4 2023 | 2023-12-31 | 1.2M | — | — |
Boundless Bio shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Boundless Bio's shares outstanding moved from 22.2M to 22.4M, a change of 167,667. The latest reported quarter, Q2 2026, shows 22.5M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Boundless Bio source filings ↗